• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-(吡啶-3-基)-2-恶唑烷酮衍生物作为抗菌剂的合成及生物学评价

Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-Oxazolidinone Derivatives as Antibacterial Agents.

作者信息

Jin Bo, Wang Tong, Chen Jia-Yi, Liu Xiao-Qing, Zhang Yi-Xin, Zhang Xiu-Ying, Sheng Zun-Lai, Yang Hong-Liang

机构信息

Department of Veterinary Medicine, Northeast Agricultural University, Harbin, China.

Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, China.

出版信息

Front Chem. 2022 Jul 18;10:949813. doi: 10.3389/fchem.2022.949813. eCollection 2022.

DOI:10.3389/fchem.2022.949813
PMID:35923260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9339906/
Abstract

In this research, a series of 3-(pyridine-3-yl)-2-oxazolidinone derivatives was designed, synthesized, and evaluated for antibacterial activity, which included bacteriostatic, morphological, kinetic studies, and molecular docking. The results demonstrated that compounds , , and exhibited strong antibacterial activity similar to that of linezolid toward five Gram-positive bacteria. After observing the effect of the drug on the morphology and growth dynamics of the bacteria, the possible modes of action were predicted by molecular docking. Furthermore, the antibiofilm activity and the potential drug resistance assay was proceeded. These compounds exhibited universal antibiofilm activity and compound showed significant concentration-dependent inhibition of biofilm formation. Compound also showed a stable effect on (ATCC 49619) with less drug resistance growth for 15 days, which is much longer than that of linezolid. Overall, these results can be used to guide further exploration of novel antimicrobial agents.

摘要

在本研究中,设计、合成了一系列3-(吡啶-3-基)-2-恶唑烷酮衍生物,并对其抗菌活性进行了评估,包括抑菌、形态学、动力学研究以及分子对接。结果表明,化合物 、 、 和 对五种革兰氏阳性菌表现出与利奈唑胺相似的强抗菌活性。在观察药物对细菌形态和生长动力学影响后,通过分子对接预测了可能的作用模式。此外,还进行了抗生物膜活性和潜在耐药性测定。这些化合物表现出普遍的抗生物膜活性,化合物 对生物膜形成具有显著的浓度依赖性抑制作用。化合物 对 (ATCC 49619)也显示出稳定的效果,耐药性生长在15天内较少,这比利奈唑胺长得多。总体而言,这些结果可用于指导新型抗菌剂的进一步探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/5a9e8a40b4d8/fchem-10-949813-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/8d93313681f4/fchem-10-949813-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/8d5352115c04/FCHEM_fchem-2022-949813_wc_sch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/a2c226aeaac0/FCHEM_fchem-2022-949813_wc_sch2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/3d9627542a99/FCHEM_fchem-2022-949813_wc_sch3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/b714be9e644c/fchem-10-949813-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/a729fa9e5df4/fchem-10-949813-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/c118a41269ee/fchem-10-949813-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/d9a9ade6c243/fchem-10-949813-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/9f07efdcf4cf/fchem-10-949813-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/2ecac0078977/fchem-10-949813-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/5a9e8a40b4d8/fchem-10-949813-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/8d93313681f4/fchem-10-949813-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/8d5352115c04/FCHEM_fchem-2022-949813_wc_sch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/a2c226aeaac0/FCHEM_fchem-2022-949813_wc_sch2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/3d9627542a99/FCHEM_fchem-2022-949813_wc_sch3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/b714be9e644c/fchem-10-949813-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/a729fa9e5df4/fchem-10-949813-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/c118a41269ee/fchem-10-949813-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/d9a9ade6c243/fchem-10-949813-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/9f07efdcf4cf/fchem-10-949813-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/2ecac0078977/fchem-10-949813-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e469/9339906/5a9e8a40b4d8/fchem-10-949813-g008.jpg

相似文献

1
Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-Oxazolidinone Derivatives as Antibacterial Agents.3-(吡啶-3-基)-2-恶唑烷酮衍生物作为抗菌剂的合成及生物学评价
Front Chem. 2022 Jul 18;10:949813. doi: 10.3389/fchem.2022.949813. eCollection 2022.
2
Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine.新型含嘧啶取代哌嗪的 3-(5-氟吡啶-3-基)-2-恶唑烷酮衍生物的优化与抗菌评价。
Molecules. 2023 May 23;28(11):4267. doi: 10.3390/molecules28114267.
3
Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.新型5-(异羟肟酸)甲基恶唑烷酮衍生物的合成与生物学评价
Eur J Med Chem. 2015 Dec 1;106:120-31. doi: 10.1016/j.ejmech.2015.10.025. Epub 2015 Oct 23.
4
Oxazolidinone antimicrobials: a patent review (2012-2015).恶唑烷酮类抗菌药物:专利综述(2012 - 2015年)
Expert Opin Ther Pat. 2016 May;26(5):591-605. doi: 10.1517/13543776.2016.1168807. Epub 2016 Apr 4.
5
Genetic Determinants of Resistance to the Biofilm-Inhibitory Effects of a Synthetic 4-Oxazolidinone Analog.遗传因素对合成 4-恶唑烷酮类似物抑制生物膜效应的抗性。
Appl Environ Microbiol. 2020 Oct 1;86(20). doi: 10.1128/AEM.01120-20.
6
Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.设计、合成、分子对接研究及含喹唑啉酮片段的一些新型氟喹诺酮类似物的抗菌评价。
Daru. 2020 Dec;28(2):661-672. doi: 10.1007/s40199-020-00373-6. Epub 2020 Oct 8.
7
Design, synthesis and antibacterial evaluation of novel oxazolidinone derivatives nitrogen-containing fused heterocyclic moiety.新型噁唑烷酮衍生物含氮稠合杂环部分的设计、合成与抗菌评价。
Bioorg Med Chem Lett. 2021 Jan 15;32:127660. doi: 10.1016/j.bmcl.2020.127660. Epub 2020 Nov 2.
8
Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents.芳基亚烷基-2,4-噻唑烷二酮和若丹宁衍生物作为抗菌剂的绿色合成、生物活性评价及分子对接研究
Comb Chem High Throughput Screen. 2019;22(10):716-727. doi: 10.2174/1386207322666191127103122.
9
Synthesis and antibacterial evaluation of novel oxazolidinone derivatives containing a piperidinyl moiety.新型含哌啶基噁唑烷酮衍生物的合成与抗菌评价。
Bioorg Med Chem Lett. 2019 Dec 1;29(23):126746. doi: 10.1016/j.bmcl.2019.126746. Epub 2019 Oct 19.
10
In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.双芳基恶唑烷酮RBx 11760对革兰氏阳性菌的体外和体内活性
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7134-7145. doi: 10.1128/AAC.00453-16. Print 2016 Dec.

引用本文的文献

1
Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine.新型含嘧啶取代哌嗪的 3-(5-氟吡啶-3-基)-2-恶唑烷酮衍生物的优化与抗菌评价。
Molecules. 2023 May 23;28(11):4267. doi: 10.3390/molecules28114267.
2
Recent Advances in Pyridine Scaffold: Focus on Chemistry, Synthesis, and Antibacterial Activities.吡啶骨架的最新进展:聚焦化学、合成和抗菌活性。
Biomed Res Int. 2023 May 18;2023:9967591. doi: 10.1155/2023/9967591. eCollection 2023.
3
Comparative Assessment of Docking Programs for Docking and Virtual Screening of Ribosomal Oxazolidinone Antibacterial Agents.

本文引用的文献

1
Synthesis, Antibacterial and Anthelmintic Activity of Novel 3-(3-Pyridyl)-oxazolidinone-5-methyl Ester Derivatives.新型 3-(3-吡啶基)-恶唑烷酮-5-甲酯衍生物的合成、抑菌和驱虫活性。
Molecules. 2022 Feb 7;27(3):1103. doi: 10.3390/molecules27031103.
2
Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.设计、合成及新型 9-芳基烷基-10-甲基吖啶鎓衍生物作为高效 FtsZ 靶向抗菌剂的评价。
Eur J Med Chem. 2021 Oct 5;221:113480. doi: 10.1016/j.ejmech.2021.113480. Epub 2021 Apr 28.
3
Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for .
核糖体恶唑烷酮类抗菌剂对接及虚拟筛选中对接程序的比较评估
Antibiotics (Basel). 2023 Feb 24;12(3):463. doi: 10.3390/antibiotics12030463.
超短疗程和含TB47的间歇性口服方案在小鼠模型中对布鲁里溃疡产生稳定的治愈效果,并防止耐药性的出现。
Acta Pharm Sin B. 2021 Mar;11(3):738-749. doi: 10.1016/j.apsb.2020.11.007. Epub 2020 Nov 13.
4
Installation of an aryl boronic acid function into the external section of N-aryl-oxazolidinones: Synthesis and antimicrobial evaluation.将芳基硼酸官能团引入 N-芳基-噁唑烷酮的外部结构:合成与抗菌评价。
Eur J Med Chem. 2021 Feb 5;211:113002. doi: 10.1016/j.ejmech.2020.113002. Epub 2020 Nov 11.
5
Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of Pseudomonas aeruginosa PAO1.设计、合成及生物评价 3-氨基-2-恶唑烷酮衍生物作为铜绿假单胞菌 PAO1 的有效群体感应抑制剂。
Eur J Med Chem. 2020 May 15;194:112252. doi: 10.1016/j.ejmech.2020.112252. Epub 2020 Mar 20.
6
Optimization of biaryloxazolidinone as promising antibacterial agents against antibiotic-susceptible and antibiotic-resistant gram-positive bacteria.优化联苯恶唑烷酮类化合物,作为有潜力的抗革兰氏阳性菌抗生素,针对抗生素敏感性和耐药性菌株。
Eur J Med Chem. 2020 Jan 1;185:111781. doi: 10.1016/j.ejmech.2019.111781. Epub 2019 Oct 14.
7
Carvacrol prodrugs as novel antimicrobial agents.香芹酚前药作为新型抗菌剂。
Eur J Med Chem. 2019 Sep 15;178:515-529. doi: 10.1016/j.ejmech.2019.05.093. Epub 2019 Jun 10.
8
Differential Drivers of Antimicrobial Resistance across the World.全球抗菌药物耐药性的差异驱动因素。
Acc Chem Res. 2019 Apr 16;52(4):916-924. doi: 10.1021/acs.accounts.8b00643. Epub 2019 Mar 8.
9
The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model.TB47 化合物在布鲁里溃疡小鼠模型中对溃疡分枝杆菌具有高度杀菌作用。
Nat Commun. 2019 Jan 31;10(1):524. doi: 10.1038/s41467-019-08464-y.
10
Synthesis and mechanistic studies of diketo acids and their bioisosteres as potential antibacterial agents.二酮酸及其生物等排体作为潜在抗菌剂的合成及机理研究。
Eur J Med Chem. 2019 Feb 1;163:67-82. doi: 10.1016/j.ejmech.2018.11.053. Epub 2018 Nov 22.